Bubs Australia hits over 2-week high on positive FY24 US forecast
** Shares of Bubs Australia BUB.AX advance as much as 8%
to A$0.135, hitting their highest since Nov 24
** The dairy firm sees FY24 revenue for its United States
segment to be at least A$48 million ($31.58 million), double
that what it had achieved in FY2023
** Adds it has recorded a weekly U.S revenue of over
A$770,000 in November
** Stock has fallen ~58.3% this year as of last close
($1 = 1.5200 Australian dollars)
(Reporting by Archishma Iyer)
((Archishma.Iyer@thomsonreuters.com;))
Recent news on Bubs Australia
See all newsBubs Australia hits near two-month low as quarterly revenue declines
Bubs Australia shares set for 15% weekly gain on FDA approval for infant formula products
Bubs Australia extends rally after infant formulas get US FDA approval
Bubs Australia gets permanent FDA nod for infant formula sales in US, shares jump (updated)
Bubs Australia secures permanent FDA nod for infant formula sales in US, shares jump